US equities
|
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SKHY
$142.87
▲+0.00%
SPCX
$147.96
▲+0.00%
AAPL
$342.94
▲+0.00%
INTC
$92.03
▲+0.00%
TSLA
$368.06
▲+0.00%
MU
$904.90
▲+0.00%
SNDK
$1,371.12
▲+0.00%
NVDA
$217.09
▲+0.00%
SKHY
$142.87
▲+0.00%
SPCX
$147.96
▲+0.00%
AAPL
$342.94
▲+0.00%
INTC
$92.03
▲+0.00%
TSLA
$368.06
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Vitiligo
Recent news which mentions Vitiligo
Incyte's Topical JAK Inhibitor Under Priority FDA Review For Depigmented Skin Disorder
December 15, 2021
Tickers
INCY
Tags
INCY
News
Briefs
From
Benzinga
FDA Approves AVITA Medical Vitiligo Trial With Fewer Participants
August 16, 2021
Tickers
RCEL
Tags
General
Vitiligo
RCEL
From
Benzinga